A Phase 1, Randomized, Open-label, 2-way Cross-over Study to Evaluate the Bioequivalence Between a Single Oral Dose of Esomeprazole 40 mg Capsules and Esomeprazole 40 mg Tablets in Healthy Subjects

Trial Profile

A Phase 1, Randomized, Open-label, 2-way Cross-over Study to Evaluate the Bioequivalence Between a Single Oral Dose of Esomeprazole 40 mg Capsules and Esomeprazole 40 mg Tablets in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 23 May 2017

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Bleeding ulcer; Duodenal ulcer; Gastric ulcer; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; Jejunal ulcer; NSAID-induced ulcer; Peptic ulcer; Reflux oesophagitis; Stress ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Sponsors Takeda
  • Most Recent Events

    • 16 May 2017 Status changed from active, no longer recruiting to completed.
    • 11 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 04 Apr 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top